Department of Surgery, Medical Faculty Mannheim, Mannheim School of Medicine, Heidelberg University, Mannheim, Germany.
Department of Medical Statistics and Biomathematics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Cancer. 2020 Jan 1;126(9):1917-1928. doi: 10.1002/cncr.32735. Epub 2020 Feb 5.
Controversies exist regarding the biopsy technique of choice for the accurate diagnosis of soft-tissue sarcoma (STS). The objective of this systematic review and meta-analysis was to compare the diagnostic accuracy of core needle biopsy (CNB) versus incisional biopsy (IB) in STS with reference to the final histopathological result.
Studies regarding the diagnostic accuracy of CNB and IB in detecting STS were searched systematically in the MEDLINE and EMBASE databases. Estimates of sensitivity and specificity with associated 95% CIs for diagnostic accuracy were calculated. The risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies version 2 (QUADAS-2).
A total of 17 studies comprising 2680 patients who underwent 1582 CNBs and 241 IBs with subsequent tumor resection met the inclusion criteria. The sensitivity and specificity of CNB and IB to detect the dignity of lesions were 97% (95% CI, 95%-98%) and 99% (95% CI, 97%-99%), respectively, and 96% (95% CI, 92%-99%) and 100% (95% CI, 94%-100%), respectively. Estimates of the sensitivity and specificity of CNB and IB to detect the STS histotype were 88% (95% CI, 86%-90%) and 77% (95% CI, 72%-81%), respectively, and 93% (95% CI, 87%-97%) and 65% (95% CI, 49%-78%), respectively. Patients who underwent CNB had a significantly reduced risk of complications compared with patients who underwent IB (risk ratio, 0.14; 95% CI, 0.03-0.56 [P ≤ .01). Quality assessment of studies revealed a high risk of bias.
CNB has high accuracy in diagnosing the dignity of lesions and STS histotype in patients with suspected STS with fewer complications compared with IB. Therefore, CNB should be regarded as the primary biopsy technique.
对于软组织肉瘤(STS)的准确诊断,选择哪种活检技术仍存在争议。本系统评价和荟萃分析的目的是比较核心针活检(CNB)与切开活检(IB)在 STS 中的诊断准确性,并参考最终的组织病理学结果。
在 MEDLINE 和 EMBASE 数据库中系统地搜索关于 CNB 和 IB 诊断准确性的研究。计算诊断准确性的敏感性和特异性的估计值及其相关 95%CI。使用诊断准确性研究的质量评估 2 版(QUADAS-2)评估偏倚风险。
共有 17 项研究纳入了 2680 名患者,这些患者分别接受了 1582 次 CNB 和 241 次 IB 以及随后的肿瘤切除。CNB 和 IB 检测病变严重程度的敏感性和特异性分别为 97%(95%CI,95%-98%)和 99%(95%CI,97%-99%),96%(95%CI,92%-99%)和 100%(95%CI,94%-100%)。CNB 和 IB 检测 STS 组织类型的敏感性和特异性估计值分别为 88%(95%CI,86%-90%)和 77%(95%CI,72%-81%),93%(95%CI,87%-97%)和 65%(95%CI,49%-78%)。与接受 IB 的患者相比,接受 CNB 的患者并发症风险显著降低(风险比,0.14;95%CI,0.03-0.56 [P ≤.01])。研究质量评估显示存在高偏倚风险。
与 IB 相比,CNB 在诊断疑似 STS 患者的病变严重程度和 STS 组织类型方面具有较高的准确性,且并发症较少。因此,CNB 应被视为主要的活检技术。